154 related articles for article (PubMed ID: 17900102)
1. Calculation of lipophilicity of a large, diverse dataset of anticancer platinum complexes and the relation to cellular uptake.
Oldfield SP; Hall MD; Platts JA
J Med Chem; 2007 Oct; 50(21):5227-37. PubMed ID: 17900102
[TBL] [Abstract][Full Text] [Related]
2. Quantitative structure-property relationship study of n-octanol-water partition coefficients of some of diverse drugs using multiple linear regression.
Ghasemi J; Saaidpour S
Anal Chim Acta; 2007 Dec; 604(2):99-106. PubMed ID: 17996529
[TBL] [Abstract][Full Text] [Related]
3. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
4. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
5. Prediction of octanol-water partition coefficients of organic compounds by multiple linear regression, partial least squares, and artificial neural network.
Golmohammadi H
J Comput Chem; 2009 Nov; 30(15):2455-65. PubMed ID: 19360793
[TBL] [Abstract][Full Text] [Related]
6. Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model.
Modok S; Scott R; Alderden RA; Hall MD; Mellor HR; Bohic S; Roose T; Hambley TW; Callaghan R
Br J Cancer; 2007 Jul; 97(2):194-200. PubMed ID: 17579620
[TBL] [Abstract][Full Text] [Related]
7. Linear free energy relationship for 4-substituted (o-phenylenediamine)platinum(II) dichloride derivatives using quantum mechanical descriptors.
Costa LA; Rocha WR; De Almeida WB; Dos Santos HF
J Inorg Biochem; 2005 Feb; 99(2):575-83. PubMed ID: 15621292
[TBL] [Abstract][Full Text] [Related]
8. Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes.
Ermondi G; Caron G; Ravera M; Gabano E; Bianco S; Platts JA; Osella D
Dalton Trans; 2013 Mar; 42(10):3482-9. PubMed ID: 23263457
[TBL] [Abstract][Full Text] [Related]
9. The RP-HPLC measurement and QSPR analysis of logP(o/w) values of several Pt(II) complexes.
Platts JA; Oldfield SP; Reif MM; Palmucci A; Gabano E; Osella D
J Inorg Biochem; 2006 Jul; 100(7):1199-207. PubMed ID: 16530269
[TBL] [Abstract][Full Text] [Related]
10. Activity prediction of some nontested anticancer compounds using GA-based PLS regression models.
Nandi S; Bagchi MC
Chem Biol Drug Des; 2011 Oct; 78(4):587-95. PubMed ID: 21752199
[TBL] [Abstract][Full Text] [Related]
11. Calculation of lipophilicity for Pt(II) complexes: experimental comparison of several methods.
Tetko IV; Jaroszewicz I; Platts JA; Kuduk-Jaworska J
J Inorg Biochem; 2008 Jul; 102(7):1424-37. PubMed ID: 18289687
[TBL] [Abstract][Full Text] [Related]
12. Development of quantitative structure-activity relationships for interpretation of the migration behavior of neutral platinum(II) complexes in microemulsion electrokinetic chromatography.
Oszwałdowski S; Timerbaev AR
J Chromatogr A; 2007 Apr; 1146(2):258-63. PubMed ID: 17306810
[TBL] [Abstract][Full Text] [Related]
13. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
[TBL] [Abstract][Full Text] [Related]
14. Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.
Wang X; Guo Z
Dalton Trans; 2008 Mar; (12):1521-32. PubMed ID: 18335133
[TBL] [Abstract][Full Text] [Related]
15. A quantitative structure--activity relationship model for the intrinsic activity of uncouplers of oxidative phosphorylation.
Spycher S; Escher BI; Gasteiger J
Chem Res Toxicol; 2005 Dec; 18(12):1858-67. PubMed ID: 16359176
[TBL] [Abstract][Full Text] [Related]
16. Density functional theory and surface enhanced Raman spectroscopy characterization of novel platinum drugs.
Giese B; Deacon GB; Kuduk-Jaworska J; McNaughton D
Biopolymers; 2002; 67(4-5):294-7. PubMed ID: 12012451
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
Nandi S; Vracko M; Bagchi MC
Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
[TBL] [Abstract][Full Text] [Related]
18. The second-generation anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism.
Alberto ME; Lucas MF; Pavelka M; Russo N
J Phys Chem B; 2009 Oct; 113(43):14473-9. PubMed ID: 19778071
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
20. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
Cormanich RA; Goodarzi M; Freitas MP
Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
